Insulin Resistance/Compensatory Hyperinsulinemia, Essential Hypertension, and Cardiovascular Disease
The DOI matches its Crossref record; 42 of the 43 references it cites were found in a registry or an index.
Abstract
In 1966, Welborn et al. (1) studied 19 nondiabetic patients with essential hypertension and demonstrated that these individuals had significantly higher plasma insulin concentrations compared with a normotensive control group. Although these observations suggested that the prevalence of resistance to insulin-mediated glucose disposal would be increased in patients with essential hypertension, it wasn’t until approximately 20 yr later that several research groups demonstrated that this was the case (2–7). Although the relationship between insulin resistance, hyperinsulinemia, and essential hypertension has been extensively studied in the past 15 yr, questions continue to be raised as to the nature of the link between these variables. Indeed, there is not even consensus as to whether or not there is a physiological relationship between insulin resistance/compensatory hyperinsulinemia and blood pressure regulation. Another issue, and perhaps of greater clinical relevance, is whether the insulin resistance/compensatory hyperinsulinemia that is frequently present in patients with essential hypertension plays any role in the increased prevalence of cardiovascular disease (CVD) that is the major cause of morbidity and mortality in this clinical syndrome. The goals of this review are to address both of these issues. To begin with, the evidence in support of a role for insulin resistance and compensatory hyperinsulinemia in the pathogenesis of essential hypertension will be summarized…
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“First, hypertension is an insulin-resistant state and PA is frequently associated with hypertension [25,26].”
From Insulin sensitivity and pancreatic β-cell function in patients with primary aldosteronism (2021) · cites this paper as [26]
Citations
Cites
The Pathogenesis of Atherosclerosis — An Update
Ross, R. (1986) · New England Journal of Medicine · doi:10.1056/nejm198602203140806 · Cited by 4,877
Blood pressure, stroke, and coronary heart disease
Collins, R., Peto, R., MacMahon, S., Godwin, J., Qizilbash, N., Collins, R., MacMahon, S., Hebert, P., Eberlein, K. A., Taylor, J. O., et al. (1990) · The Lancet · doi:10.1016/0140-6736(90)90944-z · Cited by 4,491
Insulin Resistance in Essential Hypertension
Ferrannini, E., Buzzigoli, G., Bonadonna, R., Giorico, M. A., Oleggini, M., Graziadei, L., Pedrinelli, R., Brandi, L., & Bevilacqua, S. (1987) · New England Journal of Medicine · doi:10.1056/nejm198708063170605 · Cited by 2,344
Hyperinsulinemia. A link between hypertension obesity and glucose intolerance.
Modan, M., Halkin, H., Almog, S., Lusky, A., Eshkol, A., Shefi, M., Shitrit, A., & Fuchs, Z. (1985) · Journal of Clinical Investigation · doi:10.1172/jci111776 · Cited by 1,465
The pathogenesis of atherosclerosis
(1972) · American Heart Journal · doi:10.1016/0002-8703(72)90090-7 · Cited by 1,329
Relationship Between Insulin Resistance and an Endogenous Nitric Oxide Synthase Inhibitor
Stühlinger, M. C. (2002) · JAMA · doi:10.1001/jama.287.11.1420 · Cited by 581 · cited 1×
“Essentially identical findings were observed when the relationship between plasma asymmetric dimethylarginine (ADMA) concentration and insulin-mediated glucose disposal was evaluated (36).”
BackgroundSelf-citationInsulin resistance is a characteristic feature of primary hypertension independent of obesity
Pollare, T., Lithell, H., & Berne, C. (1990) · Metabolism · doi:10.1016/0026-0495(90)90071-j · Cited by 530 · cited 1×
“On the basis of these and other findings (7), approximately 50% of patients with essential hypertension can be considered to be insulin resistant and hyperinsulinemic.”
BackgroundRacial Differences in the Relation between Blood Pressure and Insulin Resistance
Saad, M. F., Lillioja, S., Nyomba, B. L., Castillo, C., Ferraro, R., De Gregorio, M., Ravussin, E., Knowler, W. C., Bennett, P. H., Howard, B. V., et al. (1991) · New England Journal of Medicine · doi:10.1056/nejm199103143241105 · Cited by 421
Resistance to Insulin-Stimulated-Glucose Uptake in Patients with Hypertension*
SHEN, D.-C., SHIEH, S.-M., FUH, M. M.-T., WU, D.-A., CHEN, Y.-D. I., & REAVEN, G. M. (1988) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-66-3-580 · Cited by 420
Self-citationYeni-Komshian, H., Carantoni, M., Abbasi, F., & Reaven, G. M. (2000) · Diabetes Care · doi:10.2337/diacare.23.2.171 · Cited by 414 · cited 1×
“Resistance to insulin-mediated glucose disposal and compensatory hyperinsulinemia are continuous variables (25), not dichotomous ones, and there is no simple way to classify a person as being insulin resistant or insulin sensitive.”
BackgroundSelf-citationMeigs, J. B. (2000) · American Journal of Epidemiology · doi:10.1093/aje/152.10.908 · Cited by 401
SERUM-INSULIN IN ESSENTIAL HYPERTENSION AND IN PERIPHERAL VASCULAR DISEASE
Welborn, T. A., Breckenridge, A., Rubinstein, A. H., Dollery, C. T., & Fraser, T. R. (1966) · The Lancet · doi:10.1016/s0140-6736(66)92132-5 · Cited by 323 · cited 1×
“(1) studied 19 nondiabetic patients with essential hypertension and demonstrated that these individuals had significantly higher plasma insulin concentrations compared with a normotensive control group.”
BackgroundInsulin Resistance, Glucose Intolerance and Hyperinsulinemia in Patients with Hypertension
Swislocki, A. L. M., Hoffman, B. B., & Reaven, G. M. (1989) · American Journal of Hypertension · doi:10.1093/ajh/2.6.419 · Cited by 316 · cited 5×
“2402 J Clin Endocrinol Metab, June 2003, 88(6):2399–2403 Reaven • Insulin Resistance, Hypertension, and CVD”
BackgroundSelf-citationInsulin Resistance, Hyperinsulinemia, and Blood Pressure: Role of Age and Obesity
Ferrannini, E., Natali, A., Capaldo, B., Lehtovirta, M., Jacob, S., & Yki-Järvinen for the European Group for the Study of Insuli, H. (1997) · Hypertension · doi:10.1161/01.hyp.30.5.1144 · Cited by 315
Insulin and blood pressure in obesity.
Lucas, C. P., Estigarribia, J. A., Darga, L. L., & Reaven, G. M. (1985) · Hypertension · doi:10.1161/01.hyp.7.5.702 · Cited by 272
Self-citationRaitakari, O. T., Porkka, K. V. K., R�nnemaa, T., Knip, M., Uhari, M., �kerblom, H. K., & Viikari, J. S. A. (1995) · Diabetologia · doi:10.1007/bf00402173 · Cited by 211
Ferrari, P., Weidmann, P., Shaw, S., Giachino, D., Riesen, W., Allemann, Y., & Heynen, G. (1991) · The American Journal of Medicine · doi:10.1016/0002-9343(91)90211-f · Cited by 207
Zavaroni, I., Bonini, L., Gasparini, P., Barilli, A. L., Zuccarelli, A., Dall'Aglio, E., Delsignore, R., & Reaven, G. M. (1999) · Metabolism · doi:10.1016/s0026-0495(99)90195-6 · Cited by 206
Self-citationLow Triglycerides–High High-Density Lipoprotein Cholesterol and Risk of Ischemic Heart Disease
Jeppesen, J., Hein, H. O., Suadicani, P., & Gyntelberg, F. (2001) · Archives of Internal Medicine · doi:10.1001/archinte.161.3.361 · Cited by 175 · cited 2×
“In a second study (31), the 2906 participants enrolled in the Copenhagen Male Study were divided into three groups on the basis of their fasting plasma TG and HDL-C concentrations.”
BackgroundMethodPrevalence of hyperinsulinaemia in patients with high blood pressure
ZAVARONI, I., MAZZA, S., DALL'AGLIO, E., GASPARINI, P., PASSERI, M., & REAVEN, G. M. (1992) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.1992.tb00529.x · Cited by 172 · cited 3×
“We have tried to estimate the number of patients with essential hypertension who are insulin resistant by measuring blood pressure and the plasma insulin response 120 min after a 75-g oral glucose challenge in an unselected population of 732 factory workers (26).”
BackgroundSelf-citationRisk factors for the development of hypertension: a 10-year longitudinal study in middle-aged men
Skarfors, E. T., Lithell, H. O., & Selinus, I. (1991) · Journal of Hypertension · doi:10.1097/00004872-199103000-00004 · Cited by 142
Facchini, F., Ida Chen, Y.-D., Clinkingbeard, C., Jeppesen, & Reaven, G. M. (1992) · American Journal of Hypertension · doi:10.1093/ajh/5.10.694 · Cited by 124
Self-citationImportance of asymmetrical dimethylarginine in cardiovascular risk
Vallance, P. J. (2001) · The Lancet · doi:10.1016/s0140-6736(01)07229-4 · Cited by 123 · cited 1×
“Plasma concentrations of ADMA, an endogenous inhibitor of nitric oxide synthase, have been shown to be predictive of CVD in several clinical syndromes (37), and Fig.”
BackgroundHYPERTENSION AND HYPERINSULINAEMIA: A RELATION IN DIABETES BUT NOT ESSENTIAL HYPERTENSION
Mbanya, J. C., Wilkinson, R., Thomas, T. H., George, K., Alberti, M. M., & Taylor, R. (1988) · The Lancet · doi:10.1016/s0140-6736(88)91538-3 · Cited by 123
Relationship Between Insulin Resistance and Hypertension
Reaven, G. M. (1991) · Diabetes Care · doi:10.2337/diacare.14.4.33 · Cited by 117 · cited 1×
“and an exaggerated degree of postprandial lipemia (28).”
BackgroundSelf-citationInsulin sensitivity and body fat distribution in normotensive offspring of hypertensive parents
Allemann, Y., Horber, F., Colombo, M., Ferrari, P., Shaw, S., Jaeger, P., & Weidmann, P. U. (1993) · The Lancet · doi:10.1016/0140-6736(93)90135-4 · Cited by 115
Insulin resistance in offspring of hypertensive parents.
Beatty, O. L., Harper, R., Sheridan, B., Atkinson, A. B., & Bell, P. M. (1993) · BMJ · doi:10.1136/bmj.307.6896.92 · Cited by 114
Fasting insulin in relation to subsequent blood pressure changes and hypertension in women.
Lissner, L., Bengtsson, C., Lapidus, L., Kristjansson, K., & Wedel, H. (1992) · Hypertension · doi:10.1161/01.hyp.20.6.797 · Cited by 108
Insulin and blood pressure among healthy children Cardiovascular risk in young finns
Taittonen, L. (1996) · American Journal of Hypertension · doi:10.1016/0895-7061(95)00345-2 · Cited by 99
Ohno, Y., Suzuki, H., Yamakawa, H., Nakamura, M., Otsuka, K., & Saruta, T. (1993) · Journal of Hypertension · doi:10.1097/00004872-199304000-00013 · Cited by 94
High Triglycerides and Low HDL Cholesterol and Blood Pressure and Risk of Ischemic Heart Disease
Jeppesen, J., Hein, H. O., Suadicani, P., & Gyntelberg, F. (2000) · Hypertension · doi:10.1161/01.hyp.36.2.226 · Cited by 84 · cited 2×
“(30) evaluated the hypothesis that blood pressure would be less predictive of CVD in individuals with the characteristic dyslipidemia of the IRS–a high TG and a low HDL-C concentration–than in those without these changes in lipid metabolism.”
BackgroundMethodAn inconsistent relationship between insulin and blood pressure in three Pacific Island populations
Collins, V., Dowse, G. K., Finch, C. F., & Zimmet, P. (1990) · Journal of Clinical Epidemiology · doi:10.1016/0895-4356(90)90104-w · Cited by 82
Insulin Resistance in Secondary Hypertension
Shamiss, A., Carroll, J., & Rosenthal, T. (1992) · American Journal of Hypertension · doi:10.1093/ajh/5.1.26 · Cited by 72 · cited 1×
“patients with secondary forms of hypertension (12, 13).”
BackgroundMarigliano, A., Tedde, R., Sechi, L. A., Pala, A., Pisanu, G., & Pacifico, A. (1990) · American Journal of Hypertension · doi:10.1093/ajh/3.7.521 · Cited by 71 · cited 1×
“patients with secondary forms of hypertension (12, 13).”
BackgroundLetter: Gentamicin-resistant Pseudomonas aeruginosa.
Rd, M. (1976) · PubMed · Cited by 65
Insulin Resistance and Abnormal Electrocardiograms in Patients With High Blood Pressure
Sheu, W. H.-H., Jeng, C.-Y., Shieh, S.-M., Fuh, M. M.-T., Shen, D. D.-C., Chen, Y.-D. I., & Reaven, G. M. (1992) · American Journal of Hypertension · doi:10.1093/ajh/5.7.444 · Cited by 50
Self-citationChen, N.-G., Abbasi, F., Lamendola, C., McLaughlin, T., Cooke, J. P., Tsao, P. S., & Reaven, G. M. (1999) · Circulation · doi:10.1161/01.cir.100.9.940 · Cited by 50 · cited 1×
“3 indicate that the binding of mononuclear cells isolated from patients with hypertension is directly related to their degree of insulin resistance as quantified by the steady state plasma glucose (SSPG) concentration at the end of a 180-min infusion of octreotide, insulin, and glucose (35).”
BackgroundSelf-citationInsulin Resistance, Compensatory Hyperinsulinemia, and Coronary Heart Disease: Syndrome X Revisited
Reaven, G. M. (2001) · Comprehensive Physiology · doi:10.1002/cphy.cp070238 · Cited by 33
Self-citationClinical review 43: Treatment of hypertension: focus on prevention of coronary heart disease
Reaven, G. M. (1993) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.76.3.8445007 · Cited by 25
Self-citationMedical Management of Diabetes and Heart Disease
Schneider, D., & Sobel, B. E. (2002) · CRC Press eBooks · doi:10.1201/9780203910382 · Cited by 11
Insulin Resistance, Compensatory Hyperinsulinemia, and Coronary Heart Disease
Reaven, G. M. (2002) · Informa Healthcare eBooks · doi:10.1201/9780203910382.ch7 · Cited by 7
Self-citationInsulin Resistance, Compensatory Hyperinsulinemia and Coronary Heart Disease: Syndrome X
Reaven, G. M. (2002) · CRC Press eBooks · doi:10.1201/b14062-8 · Cited by 5
Self-citation
Research works printed but not linked: 1
- Reaven, 1993, Treatment of hypertension; focus on prevention of coronary heart disease., J Clin Endocrinol Metab, 76, 537
Cited by
National High Blood Pressure Education Program Working Group on High Blood Pressure in Children and Adolescents (2004) · PEDIATRICS · doi:10.1542/peds.114.2.s2.555 · Cited by 6,938
Eckel, R. H., Alberti, K., Grundy, S. M., & Zimmet, P. Z. (2010) · The Lancet · doi:10.1016/s0140-6736(09)61794-3 · Cited by 6,295
Insulin and insulin resistance:
Sowers, J. R., & Frohlich, E. D. (2004) · Medical Clinics of North America · doi:10.1016/s0025-7125(03)00128-7 · Cited by 1,518
Insulin and insulin resistance.
Wilcox, G. (2005) · PubMed Central · Cited by 2,028
HYPERTENSION: Trends in Prevalence, Incidence, and Control
Hajjar, I., Kotchen, J. M., & Kotchen, T. A. (2006) · Annual Review of Public Health · doi:10.1146/annurev.publhealth.27.021405.102132 · Cited by 531
Metadata
- Authors
- Reaven, G. M.
- Affiliations
- Stanford Medicine (US)
- Corresponding author
- Reaven, Gerald M.
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2003-06-01
- Volume
- 88
- Issue
- 6
- Pages
- 2399-2403
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- OpenAlex
- W2033704972
- Semantic Scholar
- 273ddc01929a0f425076be991fd96bb78d531c52
- Cited by
- 284
- References
- 43
- Citations by year
- 2026: 2 · 2025: 6 · 2024: 4 · 2023: 6 · 2022: 7 · 2021: 8 · 2020: 7 · 2019: 4 · 2018: 7 · 2017: 12 · 2016: 8 · 2015: 7 · 2014: 10 · 2013: 17 · 2012: 14
- FWCI
- 3.63
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The Journal of Clinical Endocrinology & Metabolism (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Blood Pressure and Hypertension Studies
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Function and Risk Factors
- Keywords
- insulin resistance, compensatory hyperinsulinemia, essential hypertension, cardiovascular disease, blood pressure regulation, insulin-stimulated glucose disposal, fasting insulin
- MeSH terms
- Adaptation, Physiological, Cardiovascular Diseases, Humans, Hyperinsulinism, Hypertension, Insulin Resistance
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.